Overview

Efficacy and Safety of Varenicline in Smokers With Cardiovascular Disease Who Wish to Quit Smoking

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine whether or not varenicline will help people with cardiovascular disease quit smoking and to confirm it is safe in these patients.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Varenicline